公司资料
Alzamend Neuro 股价、新闻与催化剂
- 股票代码:
- ALZN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.84 USD (+0.55%)
收盘价
最后更新: 2026年9月17日
4.34M USD
市值
股价为何变动
最新公司动态“alz修正神经恢复符合纳斯达克上市标准”发布后，ALZN 于 2026年9月16日 收于 $1.83，较前一交易日上涨 2.81%。该变动发生在与这则公司动态对应的交易时段。
公司概览
业务概览
Alzamend Neuro is a neuroscience company focused on Alzheimer's disease and other neuropsychiatric disorders. Its story is built around high-risk CNS development and novel treatment approaches.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Alzamend sits in specialty biotechnology.
商业模式特征
The company depends on clinical validation, safety, and the ability to build a credible neuroscience franchise.
生物医药行业定位
Alzamend is a highly catalyst-sensitive CNS name whose valuation is tied to early clinical progress.
未来催化剂
- Alzamend’s catalysts are AL001 and any CNS-development step that keeps the platform alive. The company still needs stronger clinical proof.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。